SCHEMBL20358136

SCHEMBL20358136

c1cc(-c2cncc(-c3ccncc3)c2)ccn1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.65
LMNA P02545 1/20 0.65
NOTUM Q6P988 1/20 0.52
CYP2A6 P11509 1/20 0.52
PDGFRB P09619 5/20 0.48
PDGFRA P16234 5/20 0.48
QDPR P09417 1/20 0.46
EGFR P00533 1/20 0.45
PIK3CD O00329 1/20 0.45
PIK3CA P42336 1/20 0.45
PIK3CB P42338 1/20 0.45
PIK3CG P48736 1/20 0.45
KIF11 P52732 2/20 0.44
AURKA O14965 1/20 0.44
TTK P33981 1/20 0.44
AURKB Q96GD4 1/20 0.44
INCENP Q9NQS7 1/20 0.44
GRM5 P41594 1/20 0.43
KDM4E B2RXH2 1/20 0.42
PDE3B Q13370 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12068479 0.97 MAPT (0.61) MAPTLMNANOTUMCYP2A6PDGFRB
SCHEMBL18745800 0.86 CYP3A4 (0.53) MAPTLMNACYP2A6QDPRAURKA
SCHEMBL12339151 0.86 NPC1 (0.49) MAPTLMNANOTUMCYP2A6QDPR
SCHEMBL445671 0.84 MAPT (0.79) MAPTLMNANOTUMPDGFRBPDGFRA
SCHEMBL14426233 0.84 MAPT (0.79) MAPTLMNANOTUMPDGFRBPDGFRA
SCHEMBL17310765 0.84 MAPT (0.67) MAPTLMNANOTUMCYP2A6KIF11
SCHEMBL12068482 0.84 MAPT (0.79) MAPTLMNANOTUMPDGFRBPDGFRA
SCHEMBL13915993 0.84 MAPT (0.79) MAPTLMNANOTUMPDGFRBPDGFRA
SCHEMBL24492883 0.84 NOTUM (0.62) MAPTLMNANOTUMPDGFRBPDGFRA
SCHEMBL17343281 0.84 LMNA (0.46) MAPTLMNANOTUMCYP2A6PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119955116-A Metal organic framework material taking multiphase hindered Lewis acid-base pair as catalytic site, preparation and catalytic application 大连理工大学 2025-05-09 CN claimed
CN-112679750-B W-S-Cu cluster-based metal organic framework crystal material, preparation method and application thereof 江南大学 2022-02-22 CN claimed
CN-119955116-A Metal organic framework material taking multiphase hindered Lewis acid-base pair as catalytic site, preparation and catalytic application 大连理工大学 2025-05-09 CN disclosed
CN-112679750-B W-S-Cu cluster-based metal organic framework crystal material, preparation method and application thereof 江南大学 2022-02-22 CN disclosed
CN-112679750-B W-S-Cu cluster-based metal organic framework crystal material, preparation method and application thereof 江南大学 2022-02-22 CN disclosed
US-10563120-B2 Electrochromic compounds and optical articles containing them ESSILOR INTERNATIONAL (FR) 2020-02-18 US disclosed
US-20180194995-A1 ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM ESSILOR INTERNATIONAL (FR) 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194995-A1 ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM EYA2, EYA3, ALDH1A2 MAPT 133/4885LMNA 1710/4885NOTUM 1448/4885
US-10563120-B2 Electrochromic compounds and optical articles containing them EYA2, EYA3, ALDH1A2 MAPT 133/4885LMNA 1710/4885NOTUM 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.